Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy - Related Studies

Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy

This study is currently recruiting participants.

Study NCT00665106. Last updated on April 24, 2008. Information provided by Novagali Pharma

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Diabetic Macular Edema

2	Additional conditions recognized in this trial
		Diabetic Retinopathy
		Edema
		Macular Edema
		Retinal Diseases

3	More general conditions related to this trial
		Cardiovascular Diseases
		Diabetes Complications
		Diabetes Mellitus
		Diabetic Angiopathies
		Endocrine System Diseases
		Eye Diseases
		Macular Degeneration
		Retinal Degeneration
		Signs and Symptoms
		Vascular Diseases

4	Interventions listed in this trial
		NOVA63035 "Corticosteroid"

5	Sponsors listed in this trial
		Novagali Pharma